{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T04:54:20Z","timestamp":1698728060209},"reference-count":18,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2013,9,22]],"date-time":"2013-09-22T00:00:00Z","timestamp":1379808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1002\/pds.3514","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T22:04:07Z","timestamp":1381529047000},"page":"1258-1262","source":"Crossref","is-referenced-by-count":3,"title":["Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin"],"prefix":"10.1002","volume":"22","author":[{"given":"Kevin","family":"Fain","sequence":"first","affiliation":[{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health  Baltimore MD USA"},{"name":"Center for Drug Safety and Effectiveness Johns Hopkins University  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health  Baltimore MD USA"},{"name":"Center for Drug Safety and Effectiveness Johns Hopkins University  Baltimore MD USA"},{"name":"Division of General Internal Medicine, Department of Medicine Johns Hopkins Medicine  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,9,22]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1652"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.7900"},{"key":"e_1_2_4_4_1","unstructured":"U.S. Food and Drug Administration.Drug safety report: advances in FDA's safety programs for marketed drugs(2012). Available athttp:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM300946.pdf[7 July 2013]."},{"key":"e_1_2_4_5_1","unstructured":"U.S. Food and Drug Administration.Drug safety information for healthcare professionals(2013). Available at:http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/default.htm[7 July 2013]."},{"key":"e_1_2_4_6_1","unstructured":"U.S. Food and Drug Administration.Medication guides(2013). Available athttp:\/\/www.fda.gov\/drugs\/drugsafety\/ucm085729.htm[7 July 2013]."},{"key":"e_1_2_4_7_1","unstructured":"U.S. Food and Drug Administration.Guidance for industry: warnings and precautions contraindications and boxed warning sections of labeling for human prescription drug and biological products \u2013 content and format(October2011). Available athttp:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm075096.pdf[7 July 2013]."},{"key":"e_1_2_4_8_1","unstructured":"U.S. Food and Drug Administration.Approved Risk evaluation and mitigation strategies (REMS)(2013). Available athttp:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm111350.htm[7 July 2013]."},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.217"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1457"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318245a160"},{"key":"e_1_2_4_12_1","unstructured":"Department of Health and Human Services.Office of Inspector General. FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety. February2013. Available athttps:\/\/oig.hhs.gov\/oei\/reports\/oei\u201004\u201011\u201000510.pdf[7 July 2013]."},{"key":"e_1_2_4_13_1","unstructured":"U.S. Food and Drug Administration.iPledge information(2006). Available athttp:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm094307.htm[7 July 2013]."},{"key":"e_1_2_4_14_1","unstructured":"U.S. Food and Drug Administration.Briefing document for iPledge year one update(August2007). Available athttp:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007\u20104311b1\u201002\u2010ipledge.pdf[7 July 2013]."},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3481"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2013.107"},{"key":"e_1_2_4_17_1","unstructured":"U.S. Food and Drug Administration.2012 Update to FDA's strategic plan for risk communication(2012). Available athttp:\/\/www.fda.gov\/AboutFDA\/ReportsManualsForms\/Reports\/ucm183673.htm[7 July 2013]."},{"key":"e_1_2_4_18_1","unstructured":"U.S. Food and Drug Administration.Draft guidance: drug safety information \u2013 FDA's communication to the public(March2012). Available athttp:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM295217.pdf[7 July 2013]."},{"key":"e_1_2_4_19_1","unstructured":"U.S. Food and Drug Administration.Risk Evaluation and mitigation strategy (REMS) assessments: social science methodologies to assess goals related to knowledge: Public Workshop (June2012). Available athttp:\/\/www.fda.gov\/Drugs\/NewsEvents\/ucm292337.htm[7 July 2013]."}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3514","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.3514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T21:27:48Z","timestamp":1698701268000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,22]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1002\/pds.3514"],"URL":"https:\/\/doi.org\/10.1002\/pds.3514","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,22]]}}}